← Browse by Condition
Medical Condition
systemic sclerosis
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 2, Phase 1, Phase 3
ClinicalMetric tracks all active clinical trials for systemic sclerosis sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — systemic sclerosis Clinical Trials
How many clinical trials are currently recruiting for systemic sclerosis?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for systemic sclerosis, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for systemic sclerosis?
systemic sclerosis research spans Phase 1 (3 trials), Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a systemic sclerosis clinical trial?
Eligibility criteria for systemic sclerosis trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 3
Phase 2 1
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05785065 Phase 2
Recruiting
Enrollment
35 pts
Location
Canada
Sponsor
Centre hospitalier de l'Univer...
NCT07236801 Phase 1
Recruiting
Enrollment
18 pts
Location
China
Sponsor
China Immunotech (Beijing) Bio...
NCT07497087 Phase 3
Recruiting
Enrollment
448 pts
Location
United States, Argen...
Sponsor
Boehringer Ingelheim
NCT06548607 EARLY_Phase 1
Recruiting
Enrollment
20 pts
Location
China
Sponsor
Nanjing Bioheng Biotech Co., L...
NCT06925542 Phase 1
Recruiting
Enrollment
80 pts
Location
United States, Germa...
Sponsor
CRISPR Therapeutics
NCT06133244
Recruiting
Enrollment
300 pts
Location
Netherlands
Sponsor
UMC Utrecht
NCT03269630
Recruiting
Enrollment
450 pts
Location
United States
Sponsor
Louisiana State University Hea...
Related Conditions
sle systemic lupus (2) systemic sclerosis with lung involvement (1) interstitial lung disease (1) systemic lupus erythematosus sle (1) sjogren s syndrome ss (1) inflammatory myopathy (1) anti neutrophil cytoplasmic antibody associated vasculitis (1) antiphospholipid syndrome (1) anca associated vasculitis (1) idiopathic inflammatory myopathies (1) sjogren s syndrome (1) autoimmune diseases (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology